Laura Sepp-Lorenzino
Currently, Laura Sepp-Lorenzino occupies the position of Chief Scientific Officer & Executive VP at Intellia Therapeutics, Inc. She is also on the board of Oligonucleotide Therapeutics Society, Inc., Alliance for Regenerative Medicine and Taysha Gene Therapies, Inc.
In her past career she was Executive Director & Head-RNA Therapeutics at Merck & Co., Inc., VP, Head-Nucleic Acid Therapies & Research at Vertex Pharmaceuticals, Inc. and Vice President of Alnylam Pharmaceuticals, Inc.
Dr. Sepp-Lorenzino received a graduate degree and a doctorate from New York University and an undergraduate degree from Universidad de Buenos Aires.
Transactions
Date
Transaction
Value
| 01/05/2023 | 689 | Disposition at $39.1 per share. | 26,940 |
| 01/05/2023 | 1,641 | Disposition at $38.22 per share. | 62,720 |
| 01/04/2023 | 2,508 | Disposition at $37.21 per share. | 93,323 |
| 01/01/2023 | 3,500 | Derivative/Non-derivative trans. at $0 per share. | 0 |
| 08/30/2021 | 1,515 | Disposition at $158.9 per share. | 240,734 |
| 08/30/2021 | 3,932 | Disposition at $157.77 per share. | 620,352 |
| 08/30/2021 | 7,425 | Disposition at $156.79 per share. | 1,164,166 |
| 08/30/2021 | 16,115 | Disposition at $155.61 per share. | 2,507,656 |
| 08/30/2021 | 28,669 | Disposition at $154.77 per share. | 4,437,102 |
| 08/30/2021 | 20,645 | Disposition at $153.64 per share. | 3,171,898 |
| 08/30/2021 | 15,839 | Disposition at $152.75 per share. | 2,419,408 |
| 08/30/2021 | 70,000 | Derivative/Non-derivative trans. at $14.25 per share. | 997,500 |
| 08/30/2021 | 207 | Disposition at $160.47 per share. | 33,218 |
| 08/30/2021 | 2,653 | Disposition at $159.64 per share. | 423,525 |
| 08/30/2021 | 27,000 | Derivative/Non-derivative trans. at $13.4 per share. | 361,800 |
| 08/04/2021 | 126 | Disposition at $141.63 per share. | 17,846 |
| 08/04/2021 | 4,054 | Disposition at $140.73 per share. | 570,520 |
| 08/04/2021 | 2,772 | Disposition at $139.85 per share. | 387,665 |
| 08/04/2021 | 4,419 | Disposition at $138.78 per share. | 613,269 |
| 08/04/2021 | 6,344 | Disposition at $137.72 per share. | 873,696 |
| 08/04/2021 | 6,814 | Disposition at $136.79 per share. | 932,088 |
| 08/04/2021 | 1,471 | Disposition at $135.47 per share. | 199,277 |
| 08/04/2021 | 26,000 | Derivative/Non-derivative trans. at $13.4 per share. | 348,400 |
